参考文献

参考文献

［1］Abel E J，Masterson T A，Karam J A，et al.Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor Thrombus［J］.J Urol，2017，198（4）：810-816.

［2］Abel E J，Spiess P E，Margulis V，et al.Cytoreductive nephrectomy for renal cell carcinoma with venous tumor thrombus［J］.J Urol，2017，198（2）：281-288.

［3］Bertini R，Roscigno M，Freschi M，et al.Impact of venous tumour thrombus consistency（solid vs friable）on cancer-specific survival in patients with renal cell carcinoma［J］.Eur Urol，2011，60（2）：358-365.

［4］Cheng S，Chen M，Cai J.Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus：2016 edition［J］.Oncotarget，2017，8（5）：8867-8876.

［5］Dekker T J，van de Velde C J，van Bruggen D，et al.Quantitative assessment of lymph vascular space invasion（LVSI）provides important prognostic information in node-negative breast cancer［J］.Ann Oncol，2013，24（12）：2994-2998.

［6］Forner A，Reig M，Bruix J.Hepatocellular carcinoma［J］.Lancet，2018，391（10127）：1301-1314.

［7］Hamanaka R，Yokose T，Sakuma Y，et al.Prognostic impact of vascular invasion and standardization of its evaluation in stage Ⅰ non-small cell lung cancer［J］.Diagn Pathol，2015，10：17.

［8］Ieni A，Barresi V，Cardia R，et al.The micropapillary/hobnail variant of papillary thyroid carcinoma：A review of series described in the literature compared to a series from one southern Italy pathology institution［J］.Rev Endocr Metab Disord，2016，17（4）：521-527.

［9］Li J J，Yin H K，Guan D X，et al.Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis［J］.Br J Cancer，2018，118（10）：1337-1348.

［10］Ma Q，Dieterich L C，Ikenberg K，et al.Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread［J］.Sci Adv，2018，4（8）：eaat4758.

［11］Maltoni R，Fici P，Amadori D，et al.Circulating tumor cells in early breast cancer：a connection with vascular invasion［J］.Cancer Lett，2015，367（1）：43-48.

［12］Mierke C T.The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells［J］.Rep Prog Phys，2019，82（6）：064602.

［13］Montagnani F，Crivelli F，Aprile G，et al.Long-term survival after liver metastasectomy in gastric cancer：systematic review and meta-analysis of prognostic factors［J］.Cancer Treat Rev，2018，69：11-20.

［14］Sekiguchi M，Sekine S，Oda I，et al.Risk factors for lymphatic and venous involvement in endoscopically resected gastric cancer［J］.J Gastroenterol，2013，48（6）：706-712.(https://www.daowen.com)

［15］Shi J，Lai E C，Li N，et al.A new classification for hepatocellular carcinoma with portal vein tumor thrombus［J］.J Hepatobiliary Pancreat Sci，2011，18（1）：74-80.

［16］Shimada Y，Saji H，Kato Y，et al.The frequency and prognostic impact of pathological microscopic vascular invasion according to tumor size in non-small cell lung Cancer［J］.Chest，2016，149（3）：775-785.

［17］Spaans V M，Scheunhage D A，Barzaghi B，et al.Independent validation of the prognostic significance of invasion patterns in endocervical adenocarcinoma：Pattern A predicts excellent survival［J］.Gynecol Oncol，2018，151（2）：196-201.

［18］Sun J X，Shi J，Li N，et al.Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma［J］.Cancer Biol Med，2016，13（4）：452-458.

［19］Sun J，Yang L，Shi J，et al.Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus：An open-label randomized controlled trial［J］.Radiother Oncol，2019，140：20-25.

［20］Tritschler T，Kraaijpoel N，Le Gal G，et al.Venous thromboembolism：advances in diagnosis and treatment［J］.Jama，2018，320（15）：1583-1594.

［21］Visser N C M，Werner H M J，Krakstad C，et al.Type of vascular invasion in association with progress of endometrial cancer［J］.Apmis，2017，125（12）：1084-1091.

［22］Wang T，Hu H S，Feng Y X，et al.Characterisation of a novel cell line（CSQT-2）with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma［J］.Br J Cancer，2010，102（11）：1618-1626.

［23］Weichand B，Popp R，Dziumbla S，et al.S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1beta［J］.J Exp Med，2017，214（9）：2695-2713.

［24］Yang P，Li Q J，Feng Y，et al.TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma［J］.Cancer Cell，2012，22（3）：291-303.

［25］Zhang X P，Gao Y Z，Chen Z H，et al.An eastern hepatobiliary surgery hospital/portal vein tumor thrombus scoring system as an aid to decision making on hepatectomy for hepatocellular carcinoma patients with portal vein tumor thrombus：A multicenter study［J］.Hepatology，2019，69（5）：2076-2090.

［26］Zhang X P，Wang K，Wei X B，et al.An eastern hepatobiliary surgery hospital microvascular invasion scoring system in predicting prognosis of patients with hepatocellular carcinoma and microvascular invasion after R0 liver resection：A largescale，multicenter study［J］.Oncologist，2019，24（12）：e1476-e1488.

［27］Zhang X P，Jiang Y B，Zhong C Q，et al.PRMT1 promoted HCC growth and metastasis in vitro and in vivo via activating the STAT3 signalling pathway［J］.Cell Physiol Biochem，2018，47（4）：1643-1654.

［28］Zhang X P，Wang K，Guo W X，et al.Is sorafenib an optimal treatment for hepatocellular carcinoma with macrovascular invasion or metastatic disease［J］.Hepatology，2018，68（2）：786.